1
|
Li H, Zeng Y, Zhang H, Gu Z, Gong Q, Luo K. Functional gadolinium-based nanoscale systems for cancer theranostics. J Control Release 2020; 329:482-512. [PMID: 32898594 DOI: 10.1016/j.jconrel.2020.08.064] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/25/2020] [Accepted: 08/30/2020] [Indexed: 02/07/2023]
Abstract
Cancer theranostics is a new strategy for combating cancer that integrates cancer imaging and treatment through theranostic agents to provide an efficient and safe way to improve cancer prognosis. Design and synthesis of these cancer theranostic agents are crucial since these agents are required to be biocompatible, tumor-specific, imaging distinguishable and therapeutically efficacious. In this regard, several types of gadolinium (Gd)-based nanomaterials have been introduced to combine different therapeutic agents with Gd to enhance the efficacy of therapeutic agents. At the same time, the entire treatment procedure could be monitored via imaging tools due to incorporation of Gd ions, Gd chelates and Gd/other imaging probes in the theranostic agents. This review aims to overview recent advances in the Gd-based nanomaterials for cancer theranostics and perspectives for Gd nanomaterial-based cancer theranostics are provided.
Collapse
Affiliation(s)
- Haonan Li
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Yujun Zeng
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Hu Zhang
- Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA 91711, USA
| | - Zhongwei Gu
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Qiyong Gong
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Kui Luo
- Huaxi MR Research Center (HMRRC), Department of Radiology, Functional and Molecular Imaging Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
| |
Collapse
|
2
|
Ji J, Weng Q, Zhang F, Xiong F, Jin Y, Hui J, Song J, Gao J, Chen M, Li Q, Shin D, Yang X. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy. Radiology 2018; 288:612-620. [PMID: 29893649 DOI: 10.1148/radiol.2018172148] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Purpose To validate the feasibility and efficacy of intratumoral radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus (HSV) thymidine kinase (TK) and ganciclovir (GCV) (hereafter, HSV-TK/GCV) gene therapy for non-small-cell lung cancer (NSCLC). Materials and Methods This study was performed from November 11, 2015, to April 14, 2017, and included (a) in vitro experiments with human NSCLC cells to establish the proof of principle, (b) in vivo experiments using mice with subcutaneous NSCLC to further demonstrate the principle, and (c) in vivo experiments using rats with orthotopic NSCLC to validate the technical feasibility. Cells, nude mice, and nude rats were randomly divided into four groups (six animals per group): (a) combination therapy (HSV-TK/GCV combined with RFH), (b) RFH, (c) HSV-TK/GCV, and (d) phosphate-buffered saline. Data were analyzed by using the Dunnett t test or Kruskal-Wallis test. Results For in vitro experiments, the cell proliferation assay showed significantly diminished viable cells with combination therapy (mean, 0.56; 95% confidence interval [CI]: 0.44, 0.68) versus RFH (mean, 0.89; 95% CI: 0.82, 0.97), HSV-TK/GCV (mean, 0.71; 95% CI: 0.56, 0.86), and phosphate-buffered saline (mean, 1; 95% CI: 1, 1) (P < .05 for all). For in vivo experiments, optical imaging showed significantly decreased relative bioluminescence signal with combination therapy (mean, 0.71 [95% CI: 0.03, 1.39] in mice; 1.29 [95% CI: 0.51, 2.06] in rats) compared with RFH (mean, 2.66 [95% CI: 1.73, 3.59] in mice; 2.26 [95% CI: 1.51, 3.01] in rats), HSV-TK/GCV (mean, 1.37 [95% CI: 0.65, 2.08] in mice; 1.76 [95% CI: 1.20, 2.31] in rats), and phosphate-buffered saline (mean, 3.07 [95% CI: 2.50, 3.65] in mice; 2.94 [95% CI: 2.29, 3.58] in rats) (P < .001 for all). US showed that the smallest relative tumor volumes occurred with combination therapy (mean, 0.60; 95% CI: 0.15, 1.05) versus RFH (mean, 2.43; 95% CI: 1.80, 3.06), HSV-TK/GCV (mean, 1.32; 95% CI: 0.75, 1.89), and phosphate-buffered saline (mean, 2.56; 95% CI: 1.75, 3.38) (P < .05 for all) in the mouse subcutaneous model. Conclusion Intratumoral radiofrequency hyperthermia-enhanced herpes simplex virus thymidine kinase and ganciclovir gene therapy for non-small-cell lung cancer is feasible and can be guided by molecular imaging. © RSNA, 2018.
Collapse
Affiliation(s)
- Jiansong Ji
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Qiaoyou Weng
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Feng Zhang
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Fu Xiong
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Yin Jin
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Junguo Hui
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Jingjing Song
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Jun Gao
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Minjiang Chen
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Qiang Li
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - David Shin
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| | - Xiaoming Yang
- From the Image-Guided Bio-Molecular Interventions Research and Division of Interventional Radiology, Department of Radiology, University of Washington School of Medicine, 850 Republican St, S470, Seattle, WA 98109 (J.J., Q.W., F.Z., F.X., Y.J., J.S., J.G., M.C., Q.L., D.S., X.Y.); Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang Province, Department of Radiology, Zhejiang University Lishui Hospital, Lishui, Zhejiang, China (J.J., Q.W., J.H., J.S., M.C., Q.L.); and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China (Y.J., X.Y.)
| |
Collapse
|
3
|
Jin Y, Gao J, Weng Q, Xiong F, Gu S, Shivaram G, Zhang F, Yang X. Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy. Am J Cancer Res 2018; 8:502-513. [PMID: 29637004 PMCID: PMC5883099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2017] [Accepted: 10/19/2017] [Indexed: 06/08/2023] Open
Abstract
We investigated the feasibility of using radiofrequency hyperthermia (RFH) to enhance green fluorescent protein (GFP)/herpes simplex virus thymidine kinase (HSV-TK)/ganciclovir (GCV) gene therapy of cholangiocarcinoma. Cholangiocarcinoma cells and mice with cholangiocarcinoma were treated by (i) GFP/HSV-TK/plasmid combined with RFH at 42°C, followed by ganciclovir administration; (ii) HSV-TK alone; (iii) RFH alone; and (iv) saline. The therapeutic effects among different treatments were evaluated by bioluminescent optical imaging and ultrasound imaging. For the technical validation, GFP/HSV-TK/plasmid was intrabiliarily injected into pig common bile duct (CBD) walls using a needle-integrated balloon catheter with or without RFH enhancement. GFP gene expression was evaluated by optical imaging, which was correlated with histology. The results show that combination therapy of HSV-TK plus RFH significantly induced lower cell viabilities and decreased bioluminescence signals compared the other three groups, which were further confirmed by the tumor volume decrease with combination therapy, as measured by ultrasound imaging. Optical imaging of CBD tissues demonstrated an increased GFP expression in the group with RFH enhancement, compared that with non-RFH treatment. We concluded that intratumoral RFH can enhance the therapeutic effect of GFP/HSV-TK/plasmid on cholangiocarcinoma, which may open new avenues for effective treatment of this deadly disease.
Collapse
Affiliation(s)
- Yin Jin
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, China
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Jun Gao
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Qiaoyou Weng
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Fu Xiong
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Shannon Gu
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Giri Shivaram
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Feng Zhang
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| | - Xiaoming Yang
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, China
- Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of MedicineSeattle, Washington, USA
| |
Collapse
|
4
|
Luo J, Wu X, Zhou F, Zhou Y, Huang T, Liu F, Han G, Chen L, Bai W, Wu X, Sun J, Yang X. Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy. Oncotarget 2018; 7:65042-65051. [PMID: 27542255 PMCID: PMC5323137 DOI: 10.18632/oncotarget.11346] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Accepted: 08/10/2016] [Indexed: 12/28/2022] Open
Abstract
Objective Gene therapy is a frontier in modern medicine. In the present study, we explored a new technique for the effective treatment of multidrug-resistant (MDR) breast cancer by combining fully the advantages of multidisciplinary fields, including image-guided minimally invasive interventional oncology, radiofrequency technology, and direct intratumoral gene therapy. Results Combination treatment with PHSP-TK plus RFH resulted in significantly higher TK gene transfection/expression, as well as a lower cell proliferation rate and a higher cell apoptosis index, than those of control groups. In vivo validation experiments with MRI confirmed that combination therapy resulted in a significant reduction of relative tumor volume compared with those of control animals, which was supported by the results of histologic and apoptosis analyses. Materials and methods The heat shock protein promoter (PHSP) was used to precisely control the overexpression of thymidine kinase (TK) (PHSP-TK). Serial in vitro experiments were performed to confirm whether radiofrequency hyperthermia (RFH) could enhance PHSP-TK transfection and expression in a MDR breast cancer cell line (MCF7/Adr). Serial in vivo experiments were then carried out to validate the feasibility of the new technique, termed interventional RFH-enhanced direct intratumoral PHSP-TK gene therapy. The therapeutic effect of combination therapy was evaluated by MRI and confirmed by subsequent laboratory correlation. Conclusions This study has established “proof-of-principle” of a new technique, interventional RFH-enhanced local gene therapy for MDR breast cancer, which may open new avenues for the effective management of MDR breast cancers via the simultaneous integration of interventional oncology, RF technology, and direct intratumoral gene therapy.
Collapse
Affiliation(s)
- Jingfeng Luo
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Xiaotian Wu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Fei Zhou
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Yurong Zhou
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Tongchun Huang
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Fei Liu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Guocan Han
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Luming Chen
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Weixian Bai
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Xia Wu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Jihong Sun
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
| | - Xiaoming Yang
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.,Image-Guided Bio-Molecular Intervention Research, Department of Radiology, University of Washington School of Medicine, Seattle, Washington, USA
| |
Collapse
|
5
|
Shi Y, Zhang F, Bai Z, Wang J, Qiu L, Li Y, Meng Y, Valji K, Yang X. Orthotopic Esophageal Cancers: Intraesophageal Hyperthermia-enhanced Direct Chemotherapy in Rats. Radiology 2016; 282:103-112. [PMID: 27404050 DOI: 10.1148/radiol.2016152281] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Purpose To determine the feasibility of using intraesophageal radiofrequency (RF) hyperthermia to enhance local chemotherapy in a rat model with orthotopic esophageal squamous cancers. Materials and Methods The animal protocol was approved by the institutional animal care and use committee and the institutional review board. Human esophageal squamous cancer cells were transduced with luciferase lentiviral particles. Cancer cells, mice with subcutaneous cancer esophageal xenografts, and nude rats with orthotopic esophageal cancers in four study groups of six animals per group were treated with (a) combination therapy of magnetic resonance imaging heating guidewire-mediated RF hyperthermia (42°C) plus local chemotherapy (cisplatin and 5-fluorouracil), (b) chemotherapy alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline. Bioluminescent optical imaging and transcutaneous ultrasonographic imaging were used to observe bioluminescence signal and changes in tumor size among the groups over 2 weeks, which were correlated with subsequent histologic results. The nonparametric Mann-Whitney U test was used for comparisons of variables. Results Compared with chemotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF hyperthermia and chemotherapy induced the lowest cell proliferation (relative absorbance of formazan: 23.4% ± 7, 44.6% ± 7.5, 95.8% ± 2, 100%, respectively; P < .0001), rendered the smallest relative tumor volume (0.65 mm3 ± 0.15, P < .0001) and relative bioluminescence optical imaging photon signal (0.57 × 107 photons per second per square millimeter ± 0.15, P < .001) of mice with esophageal cancer xenografts, as well as the smallest relative tumor volume (0.68 mm3 ± 0.13, P < .05) and relative photon signal (0.56 × 107 photons per second per square millimeter ± 0.11. P < .001) of rat orthotopic esophageal cancers. Conclusion Intraesophageal RF hyperthermia can enhance the effect of chemotherapy on esophageal squamous cell cancers. © RSNA, 2016.
Collapse
Affiliation(s)
- Yaoping Shi
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Feng Zhang
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Zhibin Bai
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Jianfeng Wang
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Longhua Qiu
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Yonggang Li
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Yanfeng Meng
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Karim Valji
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| | - Xiaoming Yang
- From the Image-guided Biomolecular Intervention Research and Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington School of Medicine, Campus Box 358056, 850 Republican St, Room S470, Seattle, WA 98109
| |
Collapse
|
6
|
Qiu L, Zhang F, Shi Y, Bai Z, Wang J, Li Y, Lee D, Ingraham C, Feng X, Yang X. Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor Margins. Radiology 2015; 279:400-9. [PMID: 26599802 DOI: 10.1148/radiol.2015150895] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
PURPOSE To investigate the possibility of using motexafin gadolinium (MGd)-enhanced molecular magnetic resonance (MR) imaging and optical imaging to identify the true margins of gliomas. MATERIALS AND METHODS The animal protocol was approved by the institutional animal care and use committee. Thirty-six Sprague-Dawley rats with gliomas were randomized into six groups of six rats. Five groups were euthanized 15, 30, 60, 120, and 240 minutes after intravenous administration of 6 mg/kg of MGd, while one group received only saline solution as a control group. After craniotomy, optical imaging and T1-weighted MR imaging were performed to identify the tumor margins. One-way analysis of variance was used to compare optical photon intensity and MR imaging signal-to-noise ratios. Histologic analysis was performed to confirm the intracellular uptake of MGd by tumor cells and to correlate the tumor margins delineated on both optical and MR images. RESULTS Both optical imaging and T1-weighted MR imaging showed tumor margins. The highest optical photon intensity (2.6 × 10(8) photons per second per mm(2) ± 2.3 × 10(7); analysis of variance, P < .001) and MR signal-to-noise ratio (77.61 ± 2.52; analysis of variance, P = .006) were reached at 15-30 minutes after administration of MGd, with continued tumor visibility at 2-4 hours. Examination with confocal microscopy allowed confirmation that the fluorescence of optical images and MR imaging T1 enhancement exclusively originated from MGd that accumulated in the cytoplasm of tumor cells. CONCLUSION MGd-enhanced optical and MR imaging can allow determination of glioma tumor margins at the optimal time of 15-120 minutes after administration of MGd. Clinical application of these results may allow complete removal of gliomas in a hybrid surgical setting in which intraoperative optical and MR imaging are available.
Collapse
Affiliation(s)
- Longhua Qiu
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Feng Zhang
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Yaoping Shi
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Zhibin Bai
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Jianfeng Wang
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Yonggang Li
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Donghoon Lee
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Christopher Ingraham
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Xiaoyuan Feng
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| | - Xiaoming Yang
- From the Image-Guided Biomolecular Intervention Research, Department of Radiology, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109 (L.Q., F.Z., Y.S., Z.B., J.W., Y.L., D.L., C.I., X.Y.); and Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China (L.Q., X.F.)
| |
Collapse
|
7
|
Zhang F, Bai Z, Shi Y, Wang J, Li Y, Yang X. Interventional MRI-guided local delivery of agents into swine bile duct walls using MR-compatible needle-integrated balloon catheter system. NMR IN BIOMEDICINE 2015; 28:679-684. [PMID: 25900480 PMCID: PMC4441522 DOI: 10.1002/nbm.3308] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2014] [Revised: 03/11/2015] [Accepted: 03/20/2015] [Indexed: 06/04/2023]
Abstract
The purpose of this study was to investigate the feasibility of interventional MRI-guided local agent delivery into pig common bile duct (CBD) walls using a newly designed MR-compatible, needle-integrated balloon catheter system. We first designed a needle-integrated balloon catheter system that comprised of a 22 G MR-compatible Chiba biopsy needle and a conventional 12 mm × 2 cm balloon catheter. Under fluoroscopy guidance, a custom needle-balloon system was positioned in the target CBD via a transcholecystic access. T1-weighted MRI was used to localize and reposition the needle-balloon system in the target. A 0.5 mL mixture of motexafin gadolinium (MGd) and trypan blue dye as well as 5-fluorouracil was delivered into the CBD wall through the needle-balloon system. Post-infusion T1-weighted MRI was obtained and contrast-to-noise ratios (CNRs) of CBD walls of pre- and post-MGd-blue infusions were compared by a paired t-test. In addition, post-infusion x-ray cholangiography was achieved to evaluate the potential injuries of CBDs by the needle-balloon system. Subsequent histologic analysis was performed to correlate and confirm the imaging findings. A post-infusion cholangiogram did not show any extravasation of contrast agent, indicating no procedure-related damage to the CBDs. MRI demonstrated clear enhancement of the target bile duct walls infused with MGd-trypan blue dye with average penetration depth of 4.7 ± 1.2 mm and an average MGd perfusion length of 21 ± 1.5 mm in the bile ducts and their surrounding tissues. The average CNR of the post-infusion bile ducts was significant higher than that of the pre-infusion bile ducts (110.6 ± 22 versus 5.7 ± 2.8, p < 0.0001). Histology depicted the blue dye staining and red fluorescence of MGd through the target CBD walls, which was well correlated with the imaging findings. It is feasible to use the new MR-compatible, needle-integrated balloon catheter system for intrabiliary local agent delivery into CBD walls under MRI guidance, which may open new avenues for efficient management of pancreatobiliary malignancies using MR-guided interventional oncology.
Collapse
Affiliation(s)
| | | | | | | | | | - Xiaoming Yang
- Correspondence to: Xiaoming Yang, MD, PhD, Image-Guided Bio-Molecular Intervention Section, Department of Radiology, University of Washington School of Medicine, 850 Republican Street, S470, Seattle, Washington, USA., Phone: 206-685-6967, Fax: 206-221-0647,
| |
Collapse
|
8
|
Zhou Y, Han G, Wang Y, Hu X, Li Z, Chen L, Bai W, Luo J, Zhang Y, Sun J, Yang X. Radiofrequency heat-enhanced chemotherapy for breast cancer: towards interventional molecular image-guided chemotherapy. Am J Cancer Res 2014; 4:1145-52. [PMID: 25250095 PMCID: PMC4165778 DOI: 10.7150/thno.10006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2014] [Accepted: 08/08/2014] [Indexed: 12/20/2022] Open
Abstract
Breast cancer is the most common malignancy in women worldwide. Recent developments in minimally invasive interventional radiology techniques have significantly improved breast cancer treatment. This study aimed to develop a novel technique for the local management of breast cancers using radiofrequency heat (RFH). We performed both in vitro experiments using human breast cancer cells and in vivo validation in xenograft animal models with magnetic resonance imaging (MRI) and pathological correlation to investigate the feasibility of our approach. Four treatment groups, including (1) no treatment (control), (2) RFH-only, (3) chemo (doxorubicin)-only, and (4) combination therapy with both doxorubicin and RFH, were conducted in each experiment. In vitro combination therapy significantly decreased breast cancer cell proliferation while increased their apoptosis index compared to the other three groups. MRI demonstrated a significant tumor size reduction in animals treated with combination therapy compared to those receiving other treatments in vivo. Such result was further confirmed by pathological examination. In conclusion, our findings suggests that RFH can enhance the therapeutic efficiency of doxorubicin on breast cancers, thus establishing the basis for future development of interventional molecular image-guided local chemotherapy for breast malignancies.
Collapse
|
9
|
Zhang F, Le T, Wu X, Wang H, Zhang T, Meng Y, Wei B, Soriano SS, Willis P, Kolokythas O, Yang X. Intrabiliary RF heat-enhanced local chemotherapy of a cholangiocarcinoma cell line: monitoring with dual-modality imaging--preclinical study. Radiology 2013; 270:400-8. [PMID: 24471389 DOI: 10.1148/radiol.13130866] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
PURPOSE To determine whether magnetic resonance (MR) imaging heating guidewire-mediated radiofrequency (RF) hyperthermia could enhance the therapeutic effect of gemcitabine and 5-fluorouracil (5-FU) in a cholangiocarcinoma cell line and local deposit doses of chemotherapeutic drugs in swine common bile duct (CBD) walls. MATERIALS AND METHODS The animal protocol was approved by the institutional animal care and use committee. Green fluorescent protein-labeled human cholangiocarcinoma cells and cholangiocarcinomas in 24 mice were treated with (a) combination therapy with chemotherapy (gemcitabine and 5-FU) plus RF hyperthermia, (b) chemotherapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline. Cell proliferation was quantified, and tumor changes over time were monitored with 14.0-T MR imaging and optical imaging. To enable further validation of technical feasibility, intrabiliary local delivery of gemcitabine and 5-FU was performed by using a microporous balloon with (eight pigs) or without (eight pigs) RF hyperthermia. Chemotherapy deposit doses in the bile duct walls were quantified by means of high-pressure liquid chromatography. The nonparametric Mann-Whitney U test and the paired-sample Wilcoxon signed rank test were used for data analysis. RESULTS Combination therapy induced lower mean levels of cell proliferation than chemotherapy only and RF hyperthermia only (0.39 ± 0.13 [standard deviation] vs 0.87 ± 0.10 and 1.03 ± 0.13, P < .001). Combination therapy resulted in smaller relative tumor volume than chemotherapy only and RF hyperthermia only (0.65 ± 0.03 vs 1.30 ± 0.021 and 1.37 ± 0.05, P = .001). Only in the combination therapy group did both MR imaging and optical imaging show substantial decreases in apparent diffusion coefficients and fluorescent signals in tumor masses immediately after the treatments. Chemotherapy quantification showed a higher average drug deposit dose in swine CBD walls with intrabiliary RF hyperthermia than without it (gemcitabine: 0.32 mg/g of tissue ± 0.033 vs 0.260 mg/g ± 0.030 and 5-FU: 0.660 mg/g ± 0.060 vs 0.52 mg/g ± 0.050, P < .05). CONCLUSION The use of intrabiliary MR imaging heating guidewire-mediated RF hyperthermia can enhance the chemotherapeutic effect on a human cholangiocarcinoma cell line and local drug deposition in swine CBD tissues.
Collapse
Affiliation(s)
- Feng Zhang
- From the Image-Guided Bio-Molecular Intervention Research and Section of Vascular & Interventional Radiology, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, 850 Republican St, Seattle, WA 98109
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Wang H, Zhang F, Meng Y, Zhang T, Willis P, Le T, Soriano S, Ray E, Valji K, Zhang G, Yang X. MRI-monitored intra-shunt local agent delivery of motexafin gadolinium: towards improving long-term patency of TIPS. PLoS One 2013; 8:e57419. [PMID: 23468986 PMCID: PMC3585394 DOI: 10.1371/journal.pone.0057419] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2012] [Accepted: 01/21/2013] [Indexed: 11/28/2022] Open
Abstract
Background Transjugular intrahepatic portosystemic shunt (TIPS) has become an important and effective interventional procedure in treatment of the complications related to portal hypertension. Although the primary patency of TIPS has been greatly improved due to the clinical application of cover stent-grafts, the long-term patency is still suboptimal. This study was to investigate the feasibility of using magnetic resonance imaging (MRI)-monitored intra-shunt local agent delivery of motexafin gadolinium (MGd) into shunt-vein walls of TIPS. This new technique aimed to ultimately inhibit shuntstenosis of TIPS. Methodology Human umbilical vein smooth muscle cells (SMCs) were incubated with various concentrations of MGd, and then examed by confocal microscopy and T1-map MRI. In addition, the proliferation of MGd-treated cells was evaluated. For in vivo validation, seventeen pigs underwent TIPS. Before placement of the stent, an MGd/trypan-blue mixture was locally delivered, via a microporous balloon, into eleven shunt-hepatic vein walls under dynamic MRI monitoring, while trypan-blue only was locally delivered into six shunt-hepatic vein walls as serve as controls. T1-weighted MRI of the shunt-vein walls was achieved before- and at different time points after agent injections. Contrast-to-noise ratio (CNR) of the shunt-vein wall at each time-point was measured. Shunts were harvested for subsequent histology confirmation. Principal Findings In vitro studies confirmed the capability of SMCs in uptaking MGds in a concentration-dependent fashion, and demonstrated the suppression of cell proliferation by MGds as well. Dynamic MRI displayed MGd/blue penetration into the shunt-vein walls, showing significantly higher CNR of shunt-vein walls on post-delivery images than on pre-delivery images (49.5±9.4 vs 11.2±1.6, P<0.01), which was confirmed by histology. Conclusion Results of this study indicate that MRI-monitored intra-shunt local MGd delivery is feasible and MGd functions as a potential therapeutic agent to inhibit the proliferation of SMCs, which may open alternative avenues to improve the long-term patency of TIPS.
Collapse
Affiliation(s)
- Han Wang
- Department of Radiology, Shanghai First People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Feng Zhang
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Yanfeng Meng
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Tong Zhang
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Patrick Willis
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Thomas Le
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Stephanie Soriano
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Erik Ray
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Karim Valji
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
| | - Guixiang Zhang
- Department of Radiology, Shanghai First People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xiaoming Yang
- Image-Guided Bio-Molecular Interventions Section, Department of Radiology, Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
- * E-mail:
| |
Collapse
|